Loading insider details...
Latest Form 4 (Oct 9, 2026): Exercise/Conversion of 48,147 ALLR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 9, 2026 | Allarity Therapeutics, Inc. (ALLR) | Exercise/Conversion | 48,147 | n/a |
| May 12, 2026 | IN8BIO, INC. (INAB) | Grant/Award | 22,000 | n/a |
| Apr 30, 2026 | Allarity Therapeutics, Inc. (ALLR) | Grant/Award | 133,333 | n/a |
| Jan 16, 2026 | Allarity Therapeutics, Inc. (ALLR) | Grant/Award | 133,333 | n/a |
| Oct 2, 2025 | Allarity Therapeutics, Inc. (ALLR) | Exercise/Conversion | 39,494 | n/a |
| May 12, 2025 | IN8BIO, INC. (INAB) | Grant/Award | 63,150 | n/a |
| May 8, 2025 | IN8BIO, INC. (INAB) | Disposition to Issuer | 2,049 | n/a |
| Jan 24, 2025 | Allarity Therapeutics, Inc. (ALLR) | Grant/Award | 144,441 | n/a |
| Dec 23, 2024 | IN8BIO, INC. (INAB) | Grant/Award | 47,697 | n/a |
| Oct 1, 2024 | Allarity Therapeutics, Inc. (ALLR) | Grant/Award | 118,483 | $250.0K |